1. High prevalence of hepatitis A and B nonimmunity in pediatric liver transplant recipients.
- Author
-
de St Maurice, Annabelle, Ng, G, Aryasomayajula, C, Liman, A, McDiarmid, SV, Venick, RS, and Wozniak, Laura J
- Subjects
- *
LIVER transplantation , *DISEASE prevalence , *DISEASE risk factors , *HEPATITIS viruses , *HEPATITIS A - Abstract
Background: Pediatric liver transplant recipients are at increased risk of post‐transplant infections. The purpose of this study was to quantify hepatitis A and B non‐immunity based on antibody titers in liver transplant recipients. Methods: We conducted a retrospective chart review of 107 pediatric liver transplant recipients at a single medical center from 2000 to 2017. We compared hepatitis immune patients to non‐immune patients and studied response to vaccination in patients immunized post‐transplantation. Results: Eighty‐one percent of patients had pre‐transplant immunity to hepatitis A whereas 68% had pre‐transplant immunity to hepatitis B. Post‐transplant hepatitis B immunity decreased to 33% whereas post‐transplant hepatitis A immunity remained high at 82%. Older age and time since transplantation were significantly associated with hepatitis B non‐immunity. Most patients responded to doses post‐transplantation with 78% seroconversion following hepatitis A re‐immunization and 83% seroconversion following hepatitis B re‐immunization. Conclusions: Pediatric liver transplant recipients are at risk of hepatitis A and B non‐immunity, particularly with respect to hepatitis B. Boosters post‐transplant may improve immunity to hepatitis viruses. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF